Skip to main content

Dr. Stephen R. Walsh, MDCM

Infectious Disease (Infectious Disease Physician)

  • Medicare participating

At a glance

Years since graduation
28
In the NPI registry since
2006
Medicare patients seen, 2024
54

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Infectious Disease Physician primary
    MA license 205960
  • Internal Medicine Physician
    MA license 205960

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Infectious Disease per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
54
Services billed
143
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes8549
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes6241
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes5251

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Payments from drug and device companies

In 2025, 1 companies reported 1 payments worth $34,800 in total to this clinician.

By company
Csl Behring$34,800
By type
Consulting Fee$34,800

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 11, 2025Csl Behring
Jun 11, 2025
Consulting Fee
Hizentra · Immunology
$34,800

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Massachusetts →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $31,911 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Infectious Disease clinicians in Boston

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 3, 2018), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1407828098. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.